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Recent studies have begun to identify the molecular determinants of inter-individual variabil-
ity of cardiorespiratory fitness (CRF) in response to exercise training programs. However,
we still have an incomplete picture of the molecular mechanisms underlying trainability in
response to exercise training.
Objective
We investigated baseline serum and skeletal muscle metabolomics profile and its associa-
tions with maximal power output (MPO) gains in response to 8-week of continuous endur-
ance training (ET) and high-intensity interval training (HIIT) programs matched for total units
of exercise performed (the TIMES study).
Methods
Eighty healthy sedentary young adult males were randomized to one of three groups and 70
were defined as completers (> 90% of sessions): ET (n = 30), HIIT (n = 30) and control (CO,
n = 10). For the CO, participants were asked to not exercise for 8 weeks. Serum and skeletal
muscle samples were analyzed by 1H-NMR spectroscopy. The targeted screens yielded 43
serum and 70 muscle reproducible metabolites (intraclass > 0.75; coefficient of variation <
25%). Associations of baseline metabolites with MPO trainability were explored within each
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training program via three analytical strategies: (1) correlations with gains in MPO; (2) differ-
ences between high and low responders to ET and HIIT; and (3) metabolites contributions
to the most significant pathways related to gains in MPO. The significance level was set at P
< 0.01 or false discovery rate of 0.1.
Results
The exercise programs generated similar gains in MPO (ET = 21.4 ± 8.0%; HIIT = 24.3 ±
8.5%). MPO associated baseline metabolites supported by all three levels of evidence
were: serum glycerol, muscle alanine, proline, threonine, creatinine, AMP and pyruvate for
ET, and serum lysine, phenylalanine, creatine, and muscle glycolate for HIIT. The most
common pathways suggested by the metabolite profiles were aminoacyl-tRNA biosynthe-
sis, and carbohydrate and amino acid metabolism.
Conclusion
We suggest that MPO gains in both programs are potentially associated with metabolites
indicative of baseline amino acid and translation processes with additional evidence for car-
bohydrate metabolism in ET.
Introduction
Cardiorespiratory fitness (CRF) is commonly assessed by the measurement of maximal oxygen
uptake (V̇O2MAX) or maximum power output (MPO) in incremental exercise tests leading to
exhaustion. CRF is the most widely examined human physiological functional capacity [1].
Higher levels of CRF are strongly associated with lower all-cause and cardiovascular disease
mortality [2, 3].
Current physical activity guidelines focused on health outcomes recommend that adults
engage in continuous endurance exercise at moderate-intensity for� 150 min wk-1 or at vigor-
ous-intensity for 75 min wk-1 or more [4]. Although it is well known that regular exercise is
associated with improvements in CRF [4], there is a large body of animal and human data
demonstrating that there is considerable inter-individual variability in CRF response to a stan-
dardized dose of exercise [5–9]. Typically, individual responses to standardized continuous
endurance training (ET) program have ranged from no gain up to 100% increase in V̇O2MAX
[5, 7, 10] and to 60% for MPO [11, 12] in groups of previously sedentary heathy adults. Fur-
thermore, inter-individual variability in CRF training responses has also been shown with
exposure to high-intensity interval training (HIIT) [13–16]. HIIT is characterized by repeated
intense bouts interspersed by short periods of recovery and it generally differs substantially in
exercise intensity and metabolic demands from ET [17]. HIIT has been found to produce CRF
gains comparable or superior to traditional ET exposure [18]. However, little is known on the
relationships between the baseline metabolomics profile and the CRF response patterns to ET
or HIIT programs.
It has been previously reported that genomics and muscle transcriptomic profiles were
associated with exercise response variability to ET programs [19–21]. In this context, recently,
metabolomics has emerged as an “omics” family of technologies with the potential to illumi-
nate biomarkers and metabolic pathways related to complex phenotypes [22, 23]. Metabolo-
mics involves the systematic quantification of small-molecules (metabolites) which provide
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complementary information to epigenetic events and posttranslational modifications [22]. A
metabolite profile (from blood, muscle, adipose tissue, etc) represents a dynamic signature of
cellular biochemical activity reflecting the end product of interactions among the genome,
transcriptome, proteome and the cellular and tissue environment, which can provide unique
insights on phenotypes of interest and their perturbations.
Metabolomics has already been used in a range of exercise studies as recently reviewed [24].
For example, changes in serum and plasma metabolites have been described in response to
acute and chronic adaptation to ET or HIIT programs [25–27], as well as differences in metab-
olite profile in relation to variable cross-sectional CRF levels, but not investigating MPO [28,
29]. To our knowledge, no previous study has investigated the relationships between baseline
serum or skeletal muscle metabolites with CRF or MPO trainability. Understanding the associ-
ation between the baseline metabolite profile and MPO trainability has the potential to gener-
ate new biomarkers and clarify the biology of adaptation to regular exercise. In this study,
MPO is the dependent variable. MPO as a surrogate of CRF is known to have a high test-retest
reliability level and low technical error [11].
Therefore, the present study aimed at investigating baseline serum and skeletal muscle
metabolomics profile and related metabolic pathways associated with MPO gains in sedentary




Young sedentary healthy Caucasian men (18–31 years old) were recruited through local adver-
tisement in Campinas, Brazil to participate in a longitudinal randomized controlled study.
Recruitment started in September 2016 and the last post-training assessment was performed
in June 2017. Participants were sedentary and did not engage in regular exercise defined as 30
min wk-1 at an energy expenditure of 6 METS or more in the previous 4 months. All partici-
pants provided a detailed medical history and received a medical examination that included an
electrocardiogram at rest. Participants were excluded if they were smoker, hypertensive (blood
pressure > 140/90 mm Hg), diabetic (fasting glucose > 7.0 mmol L-1), obese (defined as body
mass index > 33 kg m-2), dyslipidemic (based on medication), or presented evidence of heart
diseases, metabolic disorders, significant chronic respiratory conditions or musculoskeletal
problems interfering with exercise.
Initially, a total of 108 young men showed interest and were screened by interview (Fig 1
and S1 Checklist). Of those, 84 underwent a medical examination. Among them, 80 were
found to be eligible and were randomized via computer-generated random numbers, after
completing all baseline tests, to one of three arms: high-intensity interval training (HIIT; n =
34), continuous endurance training (ET; n = 35) and control (CO; n = 11). An unequal ran-
domization strategy with an approximately 3:1 ratio of subjects between the intervention vs.
control arms was used to ensure adequate sample size for correlation analysis and analysis of
high and low responders in the intervention groups. Subsequently, 6 participants dropped out
early in their treatment arm for personal reasons and 74 completed the intervention, including
post-tests. Finally, since the experiment study focuses primarily on mechanisms and is not an
effectiveness study, four participants were discarded from analysis due to invalid maximal
tests, as objectively determined by failure to attain maximal exertion and associated maximal
heart rate. Thus, a total of 70 participants were available for metabolomics explorations.
The sample size was calculated using G�Power 3.2.1 software [30] and determined for MPO in
terms of gains expected (~20% or ~50 W) after 8 weeks of intervention, based on data of our
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Fig 1. CONSORT flow diagram of participants in the TIMES study.
https://doi.org/10.1371/journal.pone.0212115.g001
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laboratory [31], assuming moderate effects of Cohen’s ƒ = 0.3 for within-between interaction
design [Group (ET, HIIT and CO) vs. Time (Pre and Post intervention)], r = 0.5 for correlation
design, and type I error of 0.05 for a two side-test to reach a statistical power of at least 80% [32].
The experimental procedures and possible risks associated with the study were explained to
all subjects, who provided written informed consent before participation. The study was
approved by the Research Ethics Committee from University of Campinas (CAAE:
52997216.8.0000.5404, April 2016) and conducted in conformity with the standards set by the
Declaration of Helsinki [33]. This study was included in the Brazilian Clinical Trials Registry
(ensaiosclinicos.gov.br; RBR-3rh38g; S1 Clinical trial). The study has been registered after
enrolment of participants, because trial registration was not required by the ethics committee
at the time the trial started. The authors confirm that all ongoing and related trials for this
intervention are registered.
Experimental design
Prior to intervention, resting blood and skeletal muscle biopsy samples were obtained in the
fasted state (12 h). After > 72 h, body mass and composition were measured followed by a
maximal exercise test on a cycle ergometer designed to measure MPO. The MPO test was
repeated 48 h later. About one week later, participants started the eight-week intervention pro-
tocol in their assigned arm. Maximal exercise tests were repeated after 4 weeks (to adjust train-
ing loads if necessary) and 5 days after the last exercise session. Similarly, in the control group,
resting and fasted blood and muscle biopsies were drawn at the beginning of week 8 and the
MPO test was performed 3 days later. The MPO and metabolites concentrations were used as
our primary and secondary outcomes, respectively.
Maximal exercise test
Participants were requested to remain sedentary before the MPO test and were instructed to
abstain from consuming alcohol (for 48 h), caffeine (for 12 h) and food (for 3 h) before the
test. The MPO test and retest was carried out on a cycle ergometer with electromagnetic brak-
ing (Corival 400, Lode BV, Groningen, Netherlands). After 5 min of rest on the bike, each par-
ticipant performed a 3 min warm-up at 50 W followed by workload increments of 25 W every
min at a pedaling cadence of 70–80 rpm until exhaustion [34]. Exhaustion was defined as the
incapacity to maintain a cadence of at least 70 rpm despite verbal encouragement or being
unable to keep with the current workload. Heart rate (HR) was measured during the whole
test with a cardiac monitor (S810, Polar, Kepler, Finland) and maximal heart rate (HRMAX)
was defined as the highest value over 10 s reached at MPO as described below. During the last
15 s of each exercise stage, perceived exertion was recorded with the Borg’s scale [35]. All par-
ticipants reported ratings of perceived exertion� 17 at end of the test. MPO was calculated as
Wcompleted þ ½25 � ðt=60Þ�, where Wcompleted is the last fully completed workload level and t is
the number of valid seconds in the final workload [11]. All tests were performed under con-
trolled conditions of temperature (21–23˚C) and relative humidity (50–70%).
The validity of each maximal exercise test was determined based on the achieved HRMAX in
relation to the expected HRMAX taking into account all the MPO tests performed by each sub-
ject. As reported earlier, the within-subject standard deviation of HRMAX derived from
repeated measurements reached about 4 beats min-1 [36]. We opted to use 2 x within-subject
standard deviation or 8 beats min-1 as the cutoff value. Thus, in the case of the pre-training
tests, the highest MPO was retained. In the post-training, for the MPO test be valid, the
attained HRMAX needed be within 8 beats min
-1 of the HRMAX associated with the pre-test
MPO retained.
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Exercise training
Prior to the main study, a pilot experiment was conducted with 6 subjects who performed the
initial ET and then the initial HIIT training session in order to verify their comparability by
quantifying the total amount of work performed and the total volume of exercise executed per
week in each program. The total amount of work in Joules performed was quite similar
between the two exercise sessions (HIIT: 250.2 ± 31.3 J; ET: 250.9 ± 48.5 J) as was the total
exercise volume per program calculated as [intensity (% heart rate reserve) x duration (min-
utes per session) x frequency (sessions per week) x (number of weeks) [37]. The exercise vol-
ume is reported in “Units of Exercise” and it reached 816 Units for ET and HIIT, with no
difference between the two programs.
The training programs were performed on cycle ergometers, 40 min per session, for 8 weeks.
The intensity of training was customized for each individual based on the heart rate reserve
(HRR) calculated as the difference between resting and maximum HR values [38]. For ET, par-
ticipants exercised at 70% HRR for 40 min, three times a week in the first four weeks; and at
75% HRR for 40 min, 4 times a week in the last four weeks. For HIIT, participants exercised at
50% HRR for 5 min, followed by 5 intervals of 4 min at 90% HRR (work phase) interspersed
with 3 min at 50% HRR (recovery phase), three days a week, in the first 4 weeks training: and at
60% HRR for 5 min, followed by 5 intervals of 4 min at 90% HRR and 3 min at 60% HRR, 4
days a week in the final four weeks of training. For the CO, participants were asked to not exer-
cise for 8 weeks. Control subjects were contacted after 4 weeks to remind them of the impor-
tance of remaining sedentary and to plan for the post program testing visits. Additionally, after
four- and eight-weeks, control participants were asked if they have changed their physical activ-
ity level. No change involving an increase in walking time greater 30 min a week was recorded.
All exercise sessions were supervised to ensure that the target HR (monitored by the Polar
watch and band) and cycling cadence (70–80 rpm) were maintained. The power output of the
cycle ergometer was adjusted manually in response to HR variability of each participant at all
training sessions. In each exercise session, subjects were required to reach the target HR in less
than 90 s. For the first series of exercise, after warming up, we set workload at a power output
that elicited 90% of heart rate reserve for HIIT or 70–75% of heart rate reserve for ET, based
on cardiorespiratory test. If heart rate appeared to be stable and under the target, additional
increments of 10–30 W were applied until the targeted heart rate was reached. For the subse-
quent sets of exercise sessions, we set the last workload used to reach targeted heart rate, with
workload adjustment if heart rate did not meet the target. All subjects trained in target inten-
sity zone in all exercise sessions.
Participants received constant visual feedback on pedal frequency, power output and
elapsed time. To minimize possible cardiovascular drift effects due to dehydration and
increased body temperature all subjects were encouraged to drink water which was offered ad
libitum during each exercise session whereas environmental temperature was kept the same
throughout all training sessions (21–23˚C). There was no airflow provided for cooling.
Participants were asked to remain sedentary outside of the supervised training program, to
maintain their current eating patterns, and to report important changes in their daily life rou-
tine and their use of new medications during the intervention period. No substantive changes
were recorded [i.e.none affecting hours of sleep (± 1 h per day for a week) and walking time
(> 30 min at a week)].
Body composition
Participants were asked to drink only water and not to eat or exercise for 2 h prior to the
assessment. Height and body mass were recorded using a stadiometer and digital scale (BOD
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POD; Cosmed, Chicago, USA) calibrated according to manufacturer guidelines with partici-
pants without shoes or outer garments. Next, body density was assessed using air displacement
plethysmography (BOD POD Body Composition Tracking System; Cosmed, Chicago, USA)
calibrated according to manufacturer guidelines. Body density was converted to body fat per-
centage using the Siri equation [39].
Blood and muscle tissue collection
Blood samples and muscle biopsies were collected pre-training between 7:00 and 10:00 am,
after 12 h of overnight fast. Participants were instructed to refrain from exercise and alcohol
consumption for the preceding 48 h from caffeine consumption for a minimum of 12 h. In
preparation for the first laboratory visit, participants consumed a standardized prepacked
meal containing 30% of estimated daily energy needs with the following macronutrient com-
position: 55–60% carbohydrate, 15–20% protein and 20–25% fat. Blood samples were collected
from the antecubital vein in serology tubes (Vacuette, 8 ml), centrifuged at 956 g for 10 min,
and then serum was stored at -80˚C until analysis. Muscle biopsies were obtained from the vas-
tus lateralis of the dominant leg under local anaesthetic [2–3 ml of 2% lidocaine (Xylestesin)]
using the percutaneous biopsy technique combined with suction [40]. Muscle tissue was
quickly dissected free from blood and connective tissue, and then samples were immediately
frozen in liquid nitrogen and stored at –80˚C until further analyses.
Sample preparation for NMR analysis
Serum samples were centrifuged at 20817 g for 45 min at 4˚C with a clean 3 kDa membrane
centrifuge filter (Amicon Ultra 0.5 ml, Millipore). Filtered serum (250 μL) was diluted in a
deuterium oxide solution (D2O, 99.9%; Cambridge Isotope Laboratories Inc., USA) containing
phosphate buffer (0.1 M, pH 7.4) and 0.5 mM TMSP-d4 (3-(trimethylsilyl)-2,2’,3,3’-tetradeu-
teropropionic acid from Sigma-Aldrich) to a 600 uL final solution, and then transferred to a 5
mm NMR tube (Wilmad Standard Series 5 mm, Sigma-Aldrich) for immediate NMR acquisi-
tion [41].
Muscle samples were processed based as described earlier [42, 43]. Briefly, muscle tissue
fragments (~40 mg) were weighed, added to a cold methanol/chloroform solution (2:1 v/v,
total of 2.5 mL), homogenized on ice (3 times of 30 s each, interspaced by 10 s pause) and soni-
cated for 3 min with a 10 s pause each minute. A cold chloroform/ultrapure water solution
(1:1 v/v, a total of 2.5 mL) was then added to the samples. Samples were briefly vortexed to
emulsion and centrifuged (2000 g, 30 min, at 4˚C). The upper phase containing methanol,
water, and polar metabolites was collected and evaporated in a vacuum concentrator (miVac
Duo Concentrator, GeneVac, UK). The remaining solid phase was rehydrated in 0.6 mL of
D2O-containing phosphate buffer (0.1 M, pH 7.4) and 0.5 mM of TMSPd4. Samples were
added to a 5-mm NMR tube for immediate scanning.
NMR data acquisition and metabolite identification
Each spectrum was acquired using a Proton (1H) NMR Varian Inova 1H NMR spectrometer
(Agilent Technologies Inc., Santa Clara, USA) equipped with a triple cold resonance probe
operating at a 1H resonance frequency of 599.89 MHz and a constant temperature of 298 K
(25˚C). A total of 256 free induction decays were collected with 32-k data points over a spectral
width of 8000 Hz. An acquisition time of 4 s and relaxation delay intervals of 1.5 s were imple-
mented between scans [41]. After all spectra had been acquired, phase adjustment, baseline
correction, removal of water signal (4.6–5.1 ppm), spectral calibration and quantification were
conducted following the parameters for profiling as defined in Chenomx NMR Suite software
Metabolomics and exercise training response: The TIMES study
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8.31 (Chenomx Inc., Edmonton, Canada) [44]. All spectra were processed with a line broaden-
ing (lb) of 0.5 Hz. Metabolites (methanol and ethanol) that were biased due to reagents used in
the collection and preparation of samples were not considered for further analysis.
Determination of technical error of measurement
Only metabolites with satisfactory reproducibility and coefficient of variation (CV) character-
istics were retained for the study. In the present research, reproducibility was assessed by the
within-subject standard deviation for repeated measures, commonly referred to as the techni-
cal error (TE) of measurement [45], and the intraclass correlation (ICC) coefficient. In the
case of MPO and HRMAX, the values obtained at two tests performed within 48 h at baseline
were used for the calculation of TE and CV (n = 59). For metabolomics, data obtained on a
sample of subjects recruited for the purpose of quantifying TE and CV were used (n = 11;
age = 22 ± 4 years; BMI = 23 ± 3). The subjects met the same inclusion criteria as the main
study. Two blood samples were collected at a 15-min interval in order to quantify the stability
of each serum metabolite measurement. Reproducibility and coefficient of variation measure-
ments were not performed for muscle tissue samples.
Briefly, TE was calculated by computing the within-subject standard deviation from
repeated measures divided by
p
2 [46] while CV was derived from TE divided by its measure-
ment mean multiplied by 100 [45]. Reliability of measurement was further examined with the
computation of the ICC based on a mixed model analysis of variance [47]. To minimize poten-
tial biases due to short-term, unstable metabolites or poorly reproducible assays, we consid-
ered for further analysis only serum metabolites that exhibited ICC� 0.75 and CV< 25%.
Statistical analysis
For all variables, the distributions of scores were checked for major deviation from normality.
When appropriate (skewness values > 3.0), logarithmic transformations (log2) were used to
improve normality of distributions. However, all transformed data are presented herein in
their original scale for ease of interpretation.
To compare MPO and other traits as well as metabolite concentrations among the three
groups (ET, HIIT and CO) at baseline and their changes with the interventions, we used a
one-way ANOVA followed by a Sidak’s adjustment for multiple comparisons. Additionally, a
two-way ANOVA (Mixed Linear Model) with a scaled identity covariance matrix structure
was used to assess whether there were group (ET, HIIT and CO), time (Pre- and Post-training)
and interaction group�time effects with time as a repeated measure effect, and assuming sub-
jects as a random factor. Whenever a significant F-value was obtained, Sidak’s adjustment was
performed to verify where the differences reside. In another series of comparisons, the lowest
(1st; low responders—LRE) and highest (3rd; high responders—HRE) tertiles of gains in MPO
in response to ET and HIIT were compared for baseline metabolite concentrations using a Stu-
dent unpaired t test. To identify baseline metabolites and other traits associated with MPO,
reproducible serum and skeletal muscle metabolites were correlated to gains in MPO (W) in
response to each intervention program (ET and HIIT) using Pearson correlation coefficient.
These analyses were carried out using the PASW statistics software version 18.0 (SPSS, Chi-
cago, IL).
For this exploratory and hypothesis-generating study, a large number of statistical tests
were performed. We therefore adjusted the significance level threshold at a nominal value of
P< 0.01, recognizing that a full Bonferroni adjustment is likely to be too conservative, leading
to reduced discovery from greater number of false negative observations. To supplement the
above, we calculated the 95% confidence intervals of the effect size (ES: mean difference
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divided by pooled SD from all subjects) of each baseline metabolite concentration between
LRE and HRE. If the confidence intervals did not cross zero, the difference was considered sig-
nificant [48].
To identify the most relevant baseline metabolic pathways related to MPO gains for each
program, the set of serum and skeletal muscle metabolites that had correlation coefficients of
0.2 and above (separately in ET and HIIT) were retained for pathway over-representation and
pathway topology analyses using the web-based tool MetaboAnalyst 4.0 (http://www.
metaboanalyst.ca). The pathway analysis was based on ‘Homo Sapiens’ library using Hyper-
geometric Test for Over Representation Analysis and Relative-Betweeness Centrality for Test
Pathway Topology Analysis [49]. For the pathway enrichment analysis, we used a false discov-
ery rate of 0.1 [50] to account for multiple tests while allowing for hypothesis generation to
provide good balance between controlling for false positives and being able to identify true
effects [51]. The threshold for correlation coefficient was selected on the basis of the range of
effects expected for molecular predictors of CRF trainability (0.07� r� 0.26) as observed in
previous studies [19, 20].
Finally, the baseline metabolites most associated with MPO trainability were those that
scored highly among the three levels of evidences used in the present analytical strategy: (1)
correlations with gains in MPO (r� 0.2); (2) differences between LRE and HRE; and (3)
metabolites contributions to the most significant pathways related to gains in MPO.
Results
Reproducibility analysis
Both MPO and HRMAX showed excellent reproducibility in the test-retest (48 h) situation,
with CVs lower than 3% and ICCs higher than 0.95 (Table 1). Furthermore, for the 52 serum
metabolites tested in a related pilot study of TIMES with blood samples obtained 15-min
apart, ICCs and CVs were in a range of 0.79 to 1.00 and 3–23%, respectively, for all but 9
metabolites (2-Aminobutyrate, 2-Hydroxybutyrate, 2-Oxoglutarate, Acetate, Acetoacetate,
Fumarate, Glucose,Methylamine and Oxypurinol) which had ICCs below 0.75 and CVs above
25% (S1 Table). These latter metabolites were judged to be of low reproducibility and not con-
sidered for further analysis.
Baseline characteristics
The ET, HIIT and CO groups were comparable for age, height, body mass, body fat percent-
age, body mass index (BMI), fasting glucose, systolic blood pressure, diastolic blood pressure,
HR at rest, HRMAX and estimated cardiorespiratory fitness in METS (Table 2), MPO (Table 3),
serum metabolite concentration levels (S2 Table) and skeletal muscle metabolite concentra-
tions (S3 Table) at baseline.
Table 1. Reproducibility of MPO and HRMAX based on test-retest within 48 h (n = 59) in TIMES.
Variables Mean SD TE CV% ICC
MPO (W) 236.9 ± 36.2 6.54 2.8 0.98
HRMAX (bpm min
-1) 192 ± 9 2.85 1.5 0.95
Mean and standard deviation (SD) were calculated from the data of both tests. MPO: Maximal power output;
HRMAX: Maximal heart rate; TE: Technical error defined as the within-subject standard deviation calculated from
repeated measurements; CV: Coefficient of variation derived from the technical error and the measurement mean,
expressed as a percentage; ICC: Intraclass correlation coefficient.
https://doi.org/10.1371/journal.pone.0212115.t001
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Intervention effects
Adherence to training was similar between ET and HIIT programs (97.6 ± 3.0% vs.
97.3 ± 3.5% of training sessions completed, respectively, P = 0.681). There was no difference
between the two training programs for the total amount of work performed on the cycle
ergometer across all sessions (P> 0.01). The total amount of work performed in each training
program was as follows: 8711.7 ± 1740.9 kJ for ET and 7667.0 ± 1402.7 for HIIT.
The main gain in MPO in response to ET reached 49.9 ± 15.3 W (21.4 ± 8.0%) and to HIIT
56.6 ± 17.2 W (24.3 ± 8.5%) with wide ranges from 20 to 77 W (8.3 to 39.3%) for ET and from
Table 2. Baseline characteristics of subjects in TIMES.
Variables ET (n = 30) HIIT (n = 30) CO (n = 10)
Mean ± SD Mean ± SD Mean ± SD
Age (years) 23.3 ± 3.4 23.5 ± 2.6 23.6 ± 3.5
Height (m) 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.0
Body mass (kg) 72.1 ± 12.1 72.1 ± 10.3 76.5 ± 8.4
Body fat percentage (%) 20.3 ± 7.3 21.3 ± 7.6 21.6 ± 5.7
BMI (kg m2) 23.9 ± 3.4 23.8 ± 2.7 25.0 ± 2.6
Fasting glucose (mmol L-1)a 4.0 ± 0.4 4.2 ± 0.6 3.9 ± 0.3
Systolic BP (mm Hg) 114.1 ± 13.1 116.1 ± 11.2 118.7 ± 11.0
Diastolic BP (mm Hg) 71.8 ± 10.1 74.2 ± 9.3 71.2 ± 10.5
HR at rest (beats min-1) 71 ± 9 70 ± 7 71 ± 9
HRMAX (beats min
-1) 192 ± 9 192 ± 8 195 ± 9
Cardiorespiratory fitness (METS) 12.3 ± 1.9 12.3 ± 1.8 12.1 ± 1.1
ET: Continuous endurance training; HIIT: High-intensity interval training; CO: Control; BMI: Body mass index; BP: Blood pressure; HR: Heart rate; HRMAX: Maximal
heart rate.
a Serum glucose was obtained from the metabolomics assay; at posteriori, no subject exhibited a serum glucose > 7 mmol L-1 at baseline. There were no significant
differences between groups for any variables (P> 0.01 for all one-way ANOVA tests).
https://doi.org/10.1371/journal.pone.0212115.t002
Table 3. MPO and HRMAX pre and post-intervention in TIMES.
Variables ET (n = 30) HIIT (n = 30) CO (n = 10)
Mean ± SD Mean ± SD Mean ± SD
MPO (W)abc Pre 237.5 ± 38.4 237.6 ± 32.4 249.5 ± 28.7
Post 286.5 ± 37.6�† 294.2 ± 35.3�† 239.5 ± 26.3
Δ MPO (W)a 49.0 ± 15.3† 56.6 ± 17.2† -10.0 ± 9.3
Δ MPO (%)a 21.4 ± 8.0† 24.3 ± 8.5† -3.9 ± 3.4
HRMAX (beats min
-1)b Pre 192 ± 9 192 ± 8 195 ± 9
Post 192 ± 7 191 ± 7 195 ± 12
Δ HRMAX (beats min
-1)a 0 ± 5 -1 ± 4 0 ± 5
Δ HRMAX (%)
a -0.1 ± 2.6 -0.3 ± 2.2 -0.1 ± 2.7
ET: Continuous endurance training; HIIT: High-intensity interval training; CO: Control; MPO: Maximal power output; HRMAX: Maximal heart rate; Δ: Change pre to
post-intervention.
a Baseline values and changes were analysed by one-way ANOVA.
b Interactions group�time were analysed by two-way ANOVA (Mixed Linear Model);
c Significant interaction group�time.
� Difference from pre (P < 0.01).
† Difference from CO group (P < 0.01).
https://doi.org/10.1371/journal.pone.0212115.t003
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31 to 94 W (12.9 to 44.6%) for HIIT (Table 3 and S1 Fig). There was a significant group�time
interaction effect (P< 0.001), where ET and HIIT groups increased MPO similarly from base-
line to post-training (P< 0.001 for both) while the CO group experienced no change in MPO
(P> 0.01). There were no significant differences in absolute (W), and relative (%) gains in
MPO between ET and HIIT programs, and both exercise programs registered higher gains in
MPO compared to CO group (P < 0.001 for all comparisons). There were no significant inter-
actions or main effects for HRMAX (Table 3). Additionally, no cardiovascular drift across the
duration of training sessions were observed for either training program (S2 Fig).
Associations between baseline values and MPO gains
There were no significant correlations between baseline characteristics (age, body mass, body
fat percentage, BMI, and MPO) and MPO gains with ET and HIIT programs (P> 0.01 for all,
Table 4). In the ET program, baseline serum metabolite concentration levels that were corre-
lated with the gains in MPO at r� 0.2 and better included were o-acetylcarnitine, 3-hydroxy-
butyrate, propyleneglycol and others as summarized in Table 5. In the case of baseline skeletal
muscle metabolites, alanine, glutamate, histidine, phenylalanine, proline, threonine, creati-
nine, glutathione, isobutyrate, 3-methylxanthine, AMP, 2-phosphoglycerate, histamine and
pyruvate concentrations among others were correlated with the ET gains in MPO (Table 6). In
the HIIT program, the most correlated serum metabolites included lysine, asparagine, and
tyrosine (Table 5), while baseline skeletal muscle τ-methylhistidine and glycolate were the best
correlates of the gains in MPO (Table 6).
Differences between high and low responders (HRE and LRE)
There were no significant baseline differences between HRE (upper tertile) and LRE (lower
tertile) in ET and HIIT programs for age, height, body mass, body fat percentage, BMI,
HRMAX and MPO (P> 0.01 for all, S4 Table). As expected, in both exercise programs, HRE
presented higher absolute and relative MPO gains compared to LRE (P< 0.0001 for both).
For ET program, HRE presented higher baseline serum concentration levels than LRE for
3-hydroxybutyrate (P = 0.062), glycerol (P = 0.035), methylsuccinate (P = 0.041), O-acetylcar-
nitine (P = 0.019) as revealed by the pattern of findings summarized as effect sizes and 95%
confidence intervals in Table 7. For skeletal muscle metabolites, higher concentration levels
were observed in HRE for alanine (P = 0.049), AMP (P = 0.051), creatinine (P = 0.035), proline
(P = 0.041), pyruvate (P = 0.035), threonine (P = 0.044), but lower concentrations of isobuty-
rate (P = 0.044) when compared to LRE (Table 8). In the case of the HIIT program, HRE sub-
jects showed higher baseline serum concentrations of creatine (P = 0.049) and lower
concentration levels of lysine (P = 0.054), and phenylalanine (P = 0.048) compared to LRE
Table 4. Correlation coefficients (r) between gains (Δ) in MPO (W) and baseline characteristics.
Variables ET (n = 30) HIIT (n = 30)
Δ MPO (W) Δ MPO (W)
MPO (W) -0.255 -0.091
Age (years) -0.226 0.061
Body mass (kg) -0.018 -0.090
Fat mass (%) -0.166 -0.078
BMI (kg m2) -0.183 -0.191
ET: Continuous endurance training; HIIT: High-intensity interval training; CO: Control; MPO: Maximal power
output. BMI: Body mass index. No correlation reached statistical significance (P > 0.01).
https://doi.org/10.1371/journal.pone.0212115.t004
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Table 5. Pearson correlation coefficients (r) between gains (Δ) in MPO (W) and baseline serum metabolites con-
centration levels in TIMES.
Serum metabolites# ET (n = 30) HIIT (n = 29)















































Metabolomics and exercise training response: The TIMES study
PLOS ONE | https://doi.org/10.1371/journal.pone.0212115 February 11, 2019 12 / 32
(Table 7). As for skeletal muscle metabolites, HRE displayed lower concentrations of glycolate
compared to LRE (Table 8).
Pathway analysis
For pathway analysis, baseline metabolites that were correlated at r� 0.2 with MPO gains
were used, separately for serum (ET: 13 metabolites; HIIT: 17 metabolites) and skeletal muscle
(ET: 49 metabolites; HIIT: 13 metabolites) in each exercise program. We relied on MetaboA-
nalyst 3.0, ‘Homo Sapiens’ library, and used the test for Over Representation Analysis and the
test for Pathway Topology Analysis to explore pathway enrichment as suggested by the profile
of MPO associated metabolite concentrations.
We observed multiple pathways significantly related to MPO gains for each exercise pro-
gram (Fig 2). Here, we report on pathways that were first retained at false discovery rate
threshold of 0.1 together with their “impact” score defined as the sum of connections for
matched metabolites normalized by the sum of all metabolite connections within the relevant
significant pathway [49]. The complete list of significant pathaways and related metabolites for
each training programs are sumarized in details in Fig 2.
From the 21 observed significant pathways, five were related to MPO gains in both exercise
programs (Fig 2), including metabolites supported by all the three levels of evidence, such as:
arginine and proline metabolism (Fig 2A, 2B and 2C), aminoacyl-tRNA biosynthesis (Fig 2A,
2B and 2C), glycine, serine and threonine metabolism (Fig 2B and 2C), nitrogen metabolism
(Fig 2A, 2B and 2C) and glyoxylate and dicarboxylate metabolism (Fig 2B and 2D).
Summary of metabolites and pathways associated with MPO gains
The baseline metabolites most associated with MPO trainability were identified from the three
levels of evidences described above: (1) correlations with gains in MPO (r� 0.2); (2) differ-
ences between LRE and HRE and (3) contributions of the most significant pathways related to
gains in MPO.
The baseline metabolites supported by all three levels of evidence were: serum glycerol (a c)
(Table 9), skeletal muscle alanine (b), proline (c), threonine (d), creatinine (e), AMP (f) and
pyruvate (g) for ET (Table 10). In case of HIIT, metabolites were: serum lysine (h), phenylala-
nine (i) and creatine (j) (Table 9), and skeletal muscle glycolate (k) (Table 10).
The most significant pathways associated with MPO gains suggested by the metabolites for
all three levels of evidence were: aminoacyl-tRNA biosynthesis (b, c, d, h, i); alanine, aspartate
Table 5. (Continued)
Serum metabolites# ET (n = 30) HIIT (n = 29)







ET: Continuous endurance training; HIIT: High-intensity interval training; MPO: Maximal power output; Δ: Change
pre to post intervention. LT Data log transformed before analysis. Bold values are correlation coefficients (r)� 0.2.
# Metabolites chemical taxonomy was based on class and sub-class from Human Metabolome Database.
https://doi.org/10.1371/journal.pone.0212115.t005
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Table 6. Pearson correlation coefficients (r) between gains in MPO and baseline muscle metabolites levels in TIMES.
Skeletal muscle metabolites# ET (n = 29) HIIT (n = 28)





Alanine 0.40 LT 0.01
Anserine 0.18 LT -0.24
β-Alanine 0.20 LT -0.02
Glutamate 0.40 LT 0.05
Glutamine 0.34 LT -0.04
Glycine 0.36 LT -0.08
Histidine 0.40 LT -0.06
Isoleucine 0.30 0.17
Leucine 0.13 LT 0.20
Phenylalanine 0.46 0.00
Proline 0.38 LT 0.19
Threonine 0.46 LT -0.12






Creatine 0.35 LT 0.13
Creatinephosphate -0.04 LT -0.14
Creatinine 0.38 0.02
Formate 0.23 LT 0.06
Fumarate 0.21 0.05
Glutathione 0.40 LT -0.25
Isobutyrate 0.45 LT 0.09
Isocitrate 0.26 -0.29
Maleate 0.01 0.10





Ornithine 0.30 LT -0.19
Succinate 0.20 LT 0.15
π-Methylhistidine 0.21 LT 0.04
τ-Methylhistidine -0.28 0.35 LT
Fatty acids
2-Hydroxyisocaproate 0.34 LT -0.04
3-Hydroxyisovalerate 0.33 LT 0.23
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and glutamate metabolism (b, c, g); glycine, serine and threonine metabolism (d, g, j), arginine
and proline metabolism (c, e, j); valine, leucine and isoleucine biosynthesis (d, g); taurine and
hypotaurine metabolism (b, g); nitrogen metabolism (f, i), glyoxylate and dicarboxylate metab-
olism (g, k), phenylalanine metabolism (g, h); glycerolipid metabolism (a); phenylalanine, tyro-
sine and tryptophan biosynthesis (i); purine metabolism (f), pyruvate metabolism/glycolysis or
gluconeogenesis/nicotinate and nicotinamide metabolism/citrate cycle (g) (S5 Table).
Table 6. (Continued)
Skeletal muscle metabolites# ET (n = 29) HIIT (n = 28)









ATP 0.28 LT -0.03
NAD+ 0.23 LT -0.16
NADP+ 0.11 LT -0.23
Organic oxygen compounds
2-Phosphoglycerate 0.37 0.15





Dimethylamine 0.36 LT 0.05
Histamine 0.45 LT 0.13
Methylamine 0.29 LT 0.30
N-Nitrosodimethylamine 0.22 -0.02
Trimethylamine 0.17 LT -0.15








Pyrimidine 0.11 LT 0.04
Pyruvate 0.42 -0.18
Taurine 0.18 LT -0.03
ET: Continuous endurance training; HIIT: High-intensity interval training; MPO: Maximal power output; Δ: Change pre to post intervention. LT Data log transformed
before analysis. Bold values are correlation coefficients (r)� 0.2.
# Metabolites chemical taxonomy was based on class and sub-class from Human Metabolome Database.
https://doi.org/10.1371/journal.pone.0212115.t006
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Discussion
In this study, we report on baseline targeted blood and muscle metabolites in relation to MPO
trainability in response to two different exercise training programs. Our key findings can be
summarized as follows: (i) significant and similiar improvement in MPO with ET and HIIT
programs matched for total units of exercise performed; (ii) presence of considerable inter-
individual response variability to both training programs; (iii) distinct baseline serum and skel-
etal muscle metabolic profile associated with MPO gains within each training program as well
as differences between MPO high and low responders (HRE vs LRE); (iv) specific baseline
metabolites associated with MPO gains such as serum glycerol, and skeletal muscle alanine,
AMP, creatinine, proline, pyruvate and threonine for ET; serum lysine, phenylalanine and cre-
atine for HIIT as well as skeletal muscle glycolate; and (v) pathways in baseline state arguably
associated with MPO trainability, involved in the metabolism of amino acids, carbohydrates
and perhaps translation processes.
In TIMES, the average gains in MPO was about 21% and 24% of the baseline values after
eight weeks of ET and HIIT, respectively, with the range of responses extending from 8% to
45%. Our findings agree with those of previous studies involving untrained young adults, in
which MPO gains 24% (5–65%) after 6 weeks of ET [11]; and 21% after 6 weeks of HIIT [52].
Our finding of similar MPO gains after ET and HIIT programs stands in contrast to other
reports which have suggested that HIIT generates higher CRF (and by extension MPO) gains
compared to moderate intensity ET [18, 53]. However, the two exercise programs of the pres-
ent study were perfectly matched for time, work per session, and total program units of exer-
cise, which is not always the case in previous studies. This suggests that ET programs
Table 7. Baseline differences in serum metabolites concentration levels between low responders (LRE) and high responders (HRE) to ET and HIIT programs in
TIMES. Data are mean ± standard deviation, plus confidence intervals of the effect size (ES) of differences.
Serum metabolites (mM)# ET ES 95% CI Serum metabolites (mM)# HIIT ES 95% CI
LRE (n = 10) HRE (n = 10) LRE (n = 9) HRE (n = 10)
3-Hydroxybutyrate 0.0364 ± 0.0337 0.1097 ± 0.1063� -0.93 -1.85 -0.01 3-Hydroxybutyrate 0.0830 ± 0.0641 0.1169 ± 0.1648 -0.27 -1.17 0.64
Asparagine 0.0333 ± 0.0109 0.0414 ± 0.0143 -0.64 -1.54 0.26 Asparagine 0.0402 ± 0.0115 0.0336 ± 0.0125 0.55 -0.37 1.47
Creatinine 0.0658 ± 0.0147 0.0783 ± 0.0217 -0.67 -1.57 0.23 Creatine 0.0091 ± 0.0072 0.0180 ± 0.0105� -0.97 -1.93 -0.02
Glutamine 0.3342 ± 0.0648 0.4093 ± 0.1909 -0.53 -1.42 0.37 Creatinephosphate 0.0033 ± 0.0020 0.0049 ± 0.0029 -0.65 -1.58 0.27
Glycerol 0.1797 ± 0.0382 0.2352 ± 0.0670� -1.02 -1.95 -0.09 Dimethylamine 0.0055 ± 0.0041 0.0044 ± 0.0043 0.26 -0.64 1.17
Glycolate 0.0146 ± 0.0020 0.0174 ± 0.0069 -0.54 -1.44 0.35 Guanidoacetate 0.0311 ± 0.0191 0.0456 ± 0.0203 -0.73 -1.66 0.20
Hypoxanthine 0.0031 ± 0.0007 0.0037 ± 0.0011 -0.56 -1.46 0.33 Glycerol 0.2253 ± 0.0679 0.1838 ± 0.0665 0.62 -0.30 1.54
Methionine 0.0223 ± 0.0061 0.0247 ± 0.0064 -0.39 -1.28 0.49 Histidine 0.0950 ± 0.0166 0.0876 ± 0.0106 0.54 -0.38 1.46
Methylsuccinate 0.0107 ± 0.0046 0.0145 ± 0.0030� -0.99 -1.92 -0.06 Lactate 1.9549 ± 0.5674 1.6320 ± 0.3145 0.71 -0.21 1.64
O-Acetylcarnitine 0.0040 ± 0.0025 0.0073 ± 0.0031� -1.16 -2.11 -0.22 Lysine 0.1066 ± 0.0239 0.0832 ± 0.0252� 0.95 0.00 1.90
Ornithine 0.0248 ± 0.0095 0.0350 ± 0.0170 -0.74 -1.65 0.17 Methionine 0.0212 ± 0.0092 0.0181 ± 0.0049 0.43 -0.48 1.34
Propylene glycol 0.0143 ± 0.0047 0.0188 ± 0.0049 -0.92 -1.85 0.00 N.N-Dimethylglycine 0.0032 ± 0.0005 0.0028 ± 0.0007 0.57 -0.35 1.49
Threonine 0.1164 ± 0.0140 0.1371 ± 0.0450 -0.62 -1.52 0.28 N-Methylhydantoin 0.0012 ± 0.0005 0.0016 ± 0.0008 -0.66 -1.59 0.26
Phenylalanine 0.0651 ± 0.0146 0.0545 ± 0.0058� 0.98 0.03 1.93
Trimethylamine 0.0020 ± 0.0007 0.0018 ± 0.0006 0.32 -0.59 1.22
Tyrosine 0.0758 ± 0.0164 0.0640 ± 0.0079 0.94 -0.01 1.89
Urea 0.5102 ± 0.1680 0.6089 ± 0.2848 -0.42 -1.33 0.49
ET: Continuous endurance training; HIIT: High-intensity interval training; LRE and HRE were stratified by the 1st and 3rd tertiles, respectively, from the gains in
maximal power output (MPO) in response to ET and HIIT. ES: Effect size calculated as the standardized difference between HRE and LRE in standard deviation units;
CI: Confidence intervals.
# Set of metabolites with correlation coefficients (r) between baseline values and (MPO) gains higher than 0.2.
�Difference from LRE (as determined by the 95% CI for ES that did not cross zero), bold values.
https://doi.org/10.1371/journal.pone.0212115.t007
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Fig 2. Summary of baseline serum and skeletal muscle pathways suggested to be related to MPO gains under continuous endurance training (ET) and
high-intensity interval training (HIIT) programs in TIMES. The numbers in the figure panels refer to pathways that were most enriched. Pathway numbers
refer to the same pathways across all 4 panels. All pathways represented in the figure had a false discovery rate of 0.1 (see text for details). The pathway impact
on the horizontal axis is a score representing the relative contribution of all matched metabolites in relation to all metabolites in the given pathway. (1)
Arginine and proline metabolism (A: glutamine, ornithine, and creatinine; B: glutamine, ornithine, proline, creatine, and creatinine; C: guanidoacetate,
creatine, phosphocreatine, N-methylhydantoin, and urea); (2) Aminoacyl-tRNA biosynthesis (A: asparagine, glutamine, methionine and threonine; B:
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performed at moderate to high intensities in sedentary people (as in the present study) have
the potential to induce as much improvement in cardiorespiratory fitness and exercise capacity
as HIIT-based programs.
In case of ET, we observed higher baseline serum concentrations of glycerol and skeletal
muscle alanine, proline, threonine and pyruvate in HRE compared to LRE. Glycerol is the
backbone of triglyceride molecules, and its fasting blood levels are strongly influenced by adi-
pose tissue lipolysis [54, 55]. High blood concentrations of glycerol during endurance exercise
are thought to contribute to thermoregulatory and cardiovascular physiology, attenuating
dehydration and favoring better endurance performance [56]. In TIMES, we observed consis-
tent relationships between baseline glycerol levels and a glycerolipid metabolism pathway with
MPO trainability in ET. On the other hand, we found higher baseline muscle concentrations
of pyruvate in HRE. Pyruvate stands at the crossroad between cytosolic and mitochondrial
metabolism and is key in the carbon flux to the citrate cycle [57, 58]. Significant associations
between baseline muscle pyruvate metabolism, citrate cycle, glycolysis pathway, glyoxylate and
dicarboxylate metabolism and phenylalanine metabolism with MPO trainability in ET were
suggested from the metabolite profile. HRE in the ET program were also characterized by
higher concentrations of alanine, threonine, proline and creatinine. Alanine, threonine and
proline are blood glucose precursors as they can be converted to pyruvate or citrate cycle inter-
mediates [59] while creatinine is partly derived from degradation of phosphocreatine, a fast
source of energy for skeletal muscle contraction [60]. Interestingly, in the ET program, other
pathways were suggested from the exploration of the baseline metabolite profile: glycine, serine
and threonine metabolism; arginine and proline metabolism; taurine and hypotaurine metab-
olism; valine, leucine and isoleucine biosynthesis; and aminoacyl-tRNA biosynthesis, all
seemed to be contributing to MPO trainability. All three levels of evidence also provided sup-
port for the notion that higher baseline muscle AMP (adenosine monophosphate) concentra-
tion was associated with the gains in MPO, whereas the pathway analysis revealed that baseline
purine metabolism and nitrogen metabolism also associated with MPO gains. AMP is derived
from ATP and ADP hydrolysis [61]. In a state of decreased energy levels (i.e., muscle contrac-
tion or fasting), AMP concentration increases activating AMP-activated protein kinase
(AMPK), which stimulates pathways involved in carbohydrate and fatty acid catabolism to
restore ATP levels [62, 63]. Previous studies have shown that AMPK activation is related to
increased mitochondrial biogenesis and muscle adaptation to continuous endurance training
[64, 65].
In the case of exposure to the HIIT program, the three lines of evidence indicated that
higher concentrations of serum creatine and lower concentrations of serum lysine and phenyl-
alanine as well as lower skeletal muscle glycolate were associated with higher MPO gains.
Fasted serum creatine can be attributed mainly to liver synthesis from glycine, arginine and
histidine, phenylalanine, glutamine, glycine, alanine, isoleucine, threonine, and proline; C: asparagine, histidine, phenylalanine, methionine, lysine, and
tyrosine); (3) Glycine, serine and threonine metabolism (B: dimethylglycine, glycine, threonine, creatine, and pyruvate; C: guanidoacetate, N,N-
dimethylglycine, and creatine); (4) Nitrogen metabolism (A: asparagine and glutamine; B: phenylalanine, glutamine, histidine, glycine, formate, and AMP; C:
phenylalanine, tyrosine, asparagine, and histidine); (5) Phenylalanine metabolism (B: phenylalanine, pyruvate, succinate, and fumarate); (6) Alanine, aspartate
and glutamate metabolism (A: asparagine and glutamine; B: N-acetylaspartate, alanine, pyruvate, glutamine, fumarate, and succinate); (7) Glyoxylate and
dicarboxylate metabolism (B: isocitrate, formate, pyruvate, and succinate; D: isocitrate and glycolate); (8) Methane metabolism (B: glycine, formate,
trimethylamine N-oxide, dimethylamine, and methylamine; C: trimethylamine and dimethylamine); (9) Histidine metabolism (D: anserine and τ-
methylhistidine); (10) Glutathione metabolism (D: Glutathione and NADP+); (11) Pyruvate metabolism (B: pyruvate, lactate, formate, and acetate); (12)
Glutamine and glutamate metabolism (B: glutamate and glutamine); (13) Glycerolipid metabolism (A: glycerol and propylene glycol); (14) Citrate cycle (B:
succinate, isocitrate, pyruvate, and fumarate); (15) Purine metabolism (B: glutamine, ATP, ADP, and AMP); (16) Glycolysis or Gluconeogenesis (B: pyruvate,
lactate, glucose, and acetate); (17) Propanoate metabolism (B: succinate, lactate, and β-alanine); (18) Taurine and hypotaurine metabolism (B: alanine,
pyruvate, and acetate); (19) Nicotinate and nicotinamide metabolism (B: niacinamide, NAD+, pyruvate, and fumarate); (20) Valine, leucine and isoleucine
biosynthesis (B: pyruvate, threonine, and isoleucine); (21) Phenylalanine, tyrosine and tryptophan biosynthesis (C: phenylalanine and tyrosine).
https://doi.org/10.1371/journal.pone.0212115.g002
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methionine. Skeletal muscle creatine is converted to phosphocreatine, which is a source of
high-energy phosphate used to produce ATP [60]. Our pathway analysis emphasized that crea-
tine is involved in arginine and proline metabolism and the glycine, serine and threonine
metabolism which were both associated with MPO gains. Previous studies have reported that
increased availability of blood and skeletal muscle creatine through supplementation can
improve ventilatory threshold and submaximal power output with HIIT programs [66, 67].
Lysine is an essential amino acid converted to acetyl CoA and a precursor of carnitine, which
contributes to the transportation of long-chain fatty acids into the mitochondria [68]. Phenyl-
alanine is another essential amino acid, and its flux provides some indication of whole body
protein breakdown in the postabsorptive state [69]. Previous studies have demonstrated lower
plasma phenylalanine and lysine and high creatinine (derived from creatine) concentrations in
healthy subjects with high CRF compared to low CRF [29]. Here, we showed that pathways in
which lysine and phenylalanine participate (such as phenylalanine tyrosine and tryptophan
biosynthesis, nitrogen metabolism, and aminoacyl-tRNA biosynthesis) were related to MPO
trainability in HIIT. Glycolate is a hydroxy monocarboxylic acid anion that is oxidized to
glyoxylate which is a precursor of oxalate [70, 71]. It has been shown that the activity of the cal-
cium dependent ATPase which activates the transport of calcium is itself inhibited by oxalate
[72, 73]. It is tempting to speculate that lower levels of glycolate may be associated with
reduced inhibition of calcium dependent ATPase, perhaps contributing to CRF regulation.
Furthermore, the lower skeletal muscle glycolate and its association with higher MPO gains
suggested the involvement of glyoxylate and dicarboxylate metabolism pathway. Although the
glycolate function in skeletal muscle is largely unknown, one recent study has shown increased
glyoxylate and dicarboxylate metabolism in plantaris muscle of trained rats (5 h after last exer-
cise training) compared to sedentary controls [74].
Our findings suggest that MPO training response to ET is influenced by baseline metabolite
levels reflecting metabolism of carbohydrates, amino acids and lipids, with pyruvate playing a
pivotal role. On the other hand, for HIIT, baseline and fasting levels of amino acids were asso-
ciated with MPO gains, potentially reflecting a reduced protein breakdown in high MPO
responders compared to low responders. Pathway analysis revealed that there were 5 pathways
derived from baseline metabolite profiling that were associated with MPO gains in both exer-
cise programs: aminoacyl-tRNA biosynthesis, arginine and proline metabolism, glycine, serine
and threonine metabolism, glyoxylate and dicarboxylate metabolism, and nitrogen metabo-
lism. These pathways are related mainly to amino acid metabolism and exhibit connectivity
with aminoacyl-tRNA biosynthesis. These observations confirm the importance of both amino






















Dimethylamine X Methane metabolism
ET: Continuous endurance training; HIIT: High-intensity interval training: MPO: Maximal power output; AAGM: Alanine, aspartate and glutamate metabolism
biosynthesis; AtRNAB: Aminoacyl-tRNA biosynthesis: SDKB: Synthesis and degradation of ketone bodies; APM: Arginine and proline metabolism; GSTM: Glycine,
serine and threonine metabolism; PTTB: Phenylalanine, tyrosine and tryptophan biosynthesis.
#Metabolites chemical taxonomy was based on class and sub-class from Human Metabolome Database.
$ Set of metabolites with correlation coefficients (r) between baseline values and changes in MPO higher than 0.2 at least one of the exercise training programs.
https://doi.org/10.1371/journal.pone.0212115.t009
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Table 10. Summary of evidence for baseline skeletal muscle metabolites related to MPO gains in response to ET and HIIT in TIMES.
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Proline X LRE < HRE AAGM; AtRNAB; APM
Threonine X LRE < HRE AtRNAB; GSTM; VLIB
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Table 10. (Continued)
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in young men. Future studies are encouraged to investigate baseline serum and skeletal muscle
metabolites predicitve of CRF trainability in other populations including women and different
age groups.
The present study has considerable strengths but also some limitations. Even though the
study was well powered to detect the main effect of either ET or HIIT on MPO, it is based on
small sample sizes for metabolomics study. Nonetheless, the current study is comparable in
size to previously reported studies on an aspect or another of this topic [26, 27, 29]. An impor-
tant limitation of the present research design is that it is comparing two training programs that
were only 8 weeks in duration. From other research, we understand that 8 weeks of training is
generally not sufficient to achieve the maximal training response for a given exercise dose [75].
Thus our findings are impacted in an unknown manner by the fact that subjects may not all
have reached their maximal training response with our ET or HIIT training programs in spite
of the fact that programs were matched for total unit of exercise and total work accomplished.
We also speculate that because the intensity of exercise reached substantially higher peaks in
the HIIT exercise sessions compared to the ET sessions, the association of baseline metabolite
with the MPO training gain may be different perhaps due to specific time-course patterns of
physiological adaptations in each training modality [17, 75, 76] and biological sample [77].
This would provide an explanation for the differences observed in the direction of the correla-
tions between a number of baseline serum or muscle metabolites with MPO training response
(e.g. positive correlation in one tissue but negative in the other) and observed contrast between
ET and HIIT metabolic profile. A strength of the study is that it was based on the metabolite
Table 10. (Continued)




















Dimethylamine X Methane metabolism
Histamine X Histidine metabolism
Methylamine X X
N-Nitrosodimethylamine X






Pyruvate X LRE < HRE AAGM; Citrate cycle; GSTM; Glycolysis
or Gluconeogenesis; Pyruvate
metabolism; THM; Phenylalanine
metabolism; GDM; VLIB; Butanoate
metabolism
ET: Continuous endurance training; HIIT: High-intensity interval training; MPO: Maximal power output; AAGM: Alanine, aspartate and glutamate metabolism;
GSTM: Glycine, serine and threonine metabolism; GDM: Glyoxylate and dicarboxylate metabolism; AtRNAB: Aminoacyl-tRNA biosynthesis; GGM: Glutamine and
glutamate metabolism; NNM: Nicotinate and nicotinamide metabolism; APM: Arginine and proline metabolism; THM: Taurine and hypotaurine metabolism; VLIB:
Valine, leucine and isoleucine biosynthesis.
#Metabolites chemical taxonomy was based on class and sub-class from Human Metabolome Database.
$Set of metabolites with correlation coefficients (r) between baseline values and changes in MPO higher than 0.2 at least one of the exercise training programs.
https://doi.org/10.1371/journal.pone.0212115.t010
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profiles in both serum and muscle. As our metabolomics exploration was targeted, a limited
number of metabolites were considered. However, a major effort was made to base the metab-
olite and pathway analyses solely on those metabolites that exhibited excellent reproducibility.
Low to moderate reproducibility of the excluded metabolites were attributed mainly to spec-
trum areas overlapping with other metabolites or possibly to dynamic changes in fasting
metabolism and ketone body metabolism. We aimed at parsimonious solutions by focusing
primarily on metabolites and pathways that were supported by all types of analytical strategies
employed in this report. The discussion of our findings and conclusions are essentially based
on the commonality among three lines of evidence as defined herein. Total control over diet is
almost impossible to acnhieve in free-living subjects participating in exercise training studies.
A strenght of the present study is that diet was controlled in the hours preceding baseline
blood and muscle sampling procedures with subjects receiving a standardized evening meal
and then coming to the laboratory after a 12-hour fast.
We conclude that in young sedentary men, ET programs performed at moderate to high
intensities have the potential to induce as much improvement in MPO and exercise capacity as
HIIT-based programs. However, the baseline serum and skeletal muscle metabolomics profile
and pathways associated with MPO trainability differ between ET and HIIT programs. We
observed that inter-individual response variability of MPO is associated with baseline metabo-
lites reflecting amino acid metabolism and translation processes in both exercise programs
with further associations to metabolites suggesting involvement of carbohydrate metabolism
in ET program. Replication studies are warranted.
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Luı́s Lugnani de Andrade, Arthur Fernandes Gáspari, Lucas de Marchi Silva, Silas Gabriel
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